Cinnarizine 25 mg Tablets (10 PCS)

IMPORTANT NOTICE (Rx): This product is classified as a Prescription-Only Medicine (Rx) in the Philippines. It is a targeted labyrinthine sedative and peripheral vasodilator therapy that must strictly be purchased and taken under the clinical diagnosis, guidance, and prescription of a licensed physician. Drowsiness may occur; avoid driving, operating machinery, or consuming alcohol while taking this medication.

Vertex Cinnarizine 25 mg Tablet (Targeted Vestibular Sedative & Peripheral Circulation Care Sold by blister pack of 10 pcs) is an essential oral formulation prescribed for the maintenance, control, and symptomatic relief of vestibular disorders, vertigo, motion sickness, and peripheral circulatory symptoms.

• Packaging & Quantity: Sold by blister pack of 10 pcs (1 sealed foil blister strip containing 10 tablets). Each tablet delivers 25 mg Cinnarizine.

• Selective Calcium Channel Influx Inhibition: Inhibits the transmembrane influx of calcium ions into vascular smooth muscle cells and vestibular sensory cells, suppressing overstimulation of the labyrinthine system and promoting peripheral microcirculation without altering heart rate or systemic blood pressure.

Targeted Clinical Indications:

• Maintenance therapy for vestibular symptoms including dizziness, vertigo, lightheadedness, nausea, and vomiting associated with Ménière's syndrome or inner ear imbalances.

• Prevention and relief of motion sickness (kinetosis) during travel.

• Adjunctive management of peripheral vascular disorders (such as Raynaud’s phenomenon, cold extremities, and intermittent claudication).

Directions for Use: Swallow the tablet whole with water, preferably after meals to minimize mild gastric discomfort:

• Vestibular Disorders / Vertigo: 1 tablet (25 mg) 3 times daily, or strictly as directed by your physician.

• Motion Sickness Prevention: 1 tablet (25 mg) taken at least 30 minutes to 2 hours prior to travel, repeated every 6 to 8 hours during extended trips if needed.

• Safety Precautions & Warnings: Contraindicated in patients with Parkinson's disease or a history of severe extrapyramidal symptoms. May cause somnolence or drowsiness; exercise caution when alertness is required. Avoid concurrent use with central nervous system (CNS) depressants or alcohol, as sedative effects may be potentiated. Discontinue use and consult a physician if tremors, muscle stiffness, or unusual lethargy develop.

• Storage Guidance: Store at temperatures not exceeding 30°C in a dry place protected from excessive heat, moisture, and direct sunlight. Keep the blister pack intact until use and securely out of reach of children.